Abstracts tagged "Fracture risk"

Abstract Number: 224 • 2014 ACR/ARHP Annual Meeting
Is the Protective Effect of Obesity Against Hip Fracture Due to Changes of Proximal Femur Shape?
Alexander Oldroyd¹ and Marwan Bukhari^1,2, ¹Lancaster Medical School, Lancaster University, Lancaster, United Kingdom, ²Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom
Background/Purpose: The association between increasing body mass index (BMI), increasing bone mineral density (BMD) and lower hip fracture risk has been demonstrated by previous research. Studies…
Abstract Number: 223 • 2014 ACR/ARHP Annual Meeting
Risk Factors for Clinical Vertebral Fractures in Japanese Men and Women with Rheumatoid Arthritis: Results from a Large Prospective Observational Cohort Study
Osamu Ishida¹, Takefumi Furuya², Eisuke Inoue³, Kensuke Ochi², Katsunori Ikari², Atsuo Taniguchi⁴, Hisashi Yamanaka² and Shigeki Momohara⁴, ¹Orthopedics, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ³Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, ⁴Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose: Patients with rheumatoid arthritis (RA) are at high risk of developing vertebral fractures. Previously, utilizing data from our Institute of Rheumatology Rheumatoid Arthritis (IORRA)…
Abstract Number: 2664 • 2013 ACR/ARHP Annual Meeting
Evaluation Of Osteoporosis Medication Starts In Patients Based On T-Score and FRAX® Absolute Fracture Risk Model In a Large Health Care System
Robert A. Overman^1,2 and Chad L. Deal³, ¹Eshelman School of Pharmacy - Division of Pharmaceutical Policy and Outcomes, University of North Carolina, Chapel Hill, NC, ²Rheumatology, Cleveland Clinic, Cleveland, OH, ³Dept of Rheum & Imm Dis /A 50, Cleveland Clinic, Cleveland, OH
Background/Purpose: The National Osteoporosis Foundation (NOF) 2008 guidelines recommend treatment for postmenopausal women (PMW) and men ≥ 50 if the T-score is ≤-2.5 at the…
Abstract Number: 1235 • 2013 ACR/ARHP Annual Meeting
Predictors Of Fracture In Patients With Osteopenia: Data From An Observational Cohort
Kathryn Mitchell¹, Peter Diggle¹ and Marwan Bukhari^1,2, ¹Faculty of Health and Medicine, Lancaster, United Kingdom, ²Department of Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom
Background/Purpose: The risk factors for osteoporotic fragility fractures are well documented in the literature and although they are associated with a diagnosis of established osteoporosis…
Abstract Number: 1240 • 2013 ACR/ARHP Annual Meeting
Study On The Relationship Between The Preoperative Stay and Morbimortality In Patients With Hip Fracture
Irene Martin¹, Maria Aparicio¹, Laura López-Vives¹, Montserrat Jordana¹, Antoni Coscujuela², Abelardo Montero³ and Carmen gomez-Vaquero¹, ¹Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain, ²Orthopedic Surgery Services., Hospital Universitari de Bellvitge, Barcelona, Spain, ³Internal Medicine, Hospital Universitari de Bellvitge, Barcelona, Spain
Background/Purpose: Introduction: The preoperative stay (PS) in patients with hip fracture has been classically associated with the resultant morbimortality of the process. As a consequence,…
Abstract Number: 1241 • 2013 ACR/ARHP Annual Meeting
A Low Serum 25(OH) Vitamin D Level As a Risk Factor For Incidence and Severity Of Vertebral Fracture In Glucocorticoid-Induced Osteoporosis In Japan
Mari Ushikubo¹, Harumi Kuda¹, Sayaka Kubo¹, Keisuke Izumi², Kumiko Akiya¹ and Hisaji Oshima¹, ¹Department of Connective Tissue Diseases, National Tokyo Medical Center, Tokyo, Japan, ²Division of Rheumatology, Keio University School of Medicine, Tokyo, Japan
Background/Purpose: Although levels of serum 25(OH) vitamin D (25(OH)D) have been discussed for preventing osteoporotic fractures in primary osteoporosis, an importance of the levels has…
Abstract Number: 1215 • 2013 ACR/ARHP Annual Meeting
Human Immunodeficiency Virus Infection and Fracture Risk-a Meta-analysis
Sian Yik Lim¹, Ana Marcella Rivas² and Kenneth Nugent³, ¹Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, ²Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, ³3601, Texas Tech University Health Sciences Center, Lubbock, TX
Background/Purpose: Human Immunodeficiency Virus (HIV) infection is associated with development of osteoporosis and decreased bone mineral density. However, studies have been inconclusive in whether this…
Abstract Number: 1216 • 2013 ACR/ARHP Annual Meeting
Risk Factors Associated With Fracture Occurrence Appear to Differ Between Distal Radius, Clinical Vertebral, and Hip Fractures in Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study
Kensuke Ochi¹, Takefumi Furuya¹, Yuki Go¹, Eisuke Inoue², Katsunori Ikari¹, Atsuo Taniguchi², Hisashi Yamanaka¹ and Shigeki Momohara², ¹Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose: Patients with rheumatoid arthritis (RA) are at high risk of developing fractures. Previously, utilizing data from our Institute of Rheumatology Rheumatoid Arthritis (IORRA) cohort…
Abstract Number: 1218 • 2013 ACR/ARHP Annual Meeting
Incidence Of and Risk Factors For Clinical Fractures In Patients With Systemic Lupus Erythematosus and Matched Controls: A Population-Based Study In The United Kingdom
Irene Bultink¹, Nicholas Harvey², Arief Lalmohamed^3,4, Cyrus Cooper⁵, Willem Lems⁶, Tjeerd Van Staa^2,3,7 and Frank de Vries^3,4,8,9, ¹Department of Rheumatology, VU University Medical Center, Amsterdam, Netherlands, ²University of Southampton, MRC Lifecourse Epidemiology Unit, Southampton, United Kingdom, ³Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands, ⁴Clinical Pharmacy, University Medical Center Utrecht, Utrecht, Netherlands, ⁵NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom, ⁶Rheumatology, VU University Medical Center, Amsterdam, Netherlands, ⁷Medicine and Helathcare Products Regulatory Agency, Clinical Practice Research Datalink, London, United Kingdom, ⁸Care and Public Health Research Institute, Maastricht, Netherlands, ⁹Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, Netherlands
Background/Purpose: Systemic lupus erythematosus (SLE) has been associated with an increased risk of low bone mineral density and fractures. However, data on absolute fracture risk…
Abstract Number: 700 • 2013 ACR/ARHP Annual Meeting
Osteoporosis and Fracture Risk In Outpatients With Systemic Sclerosis
Veronica Codullo¹, Flora Inverardi², Silvia Breda³, Laura Bogliolo⁴, Francesca De Nard⁵, Giovanni Cagnotto⁶, Roberto Caporali⁷ and Carlomaurizio Montecucco⁸, ¹Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, ²Rheumatology, Division of Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ³Division of Rheumatology, University of Pavia, IRCCS Foundation Policlinico S. Matteo, Pavia, Italy, ⁴IRCCS Foundation Policlinico San Matteo, Pavia, Italy, ⁵University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, ⁶IRCCS Policlinico San Matteo, Pavia, Italy, ⁷Rheumatology, Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ⁸Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
Background/Purpose: Osteoporosis (OP) is a frequent complication of a number of chronic inflammatory diseases. Only Rheumatoid Arthritis (RA) is included in the FRAX algorythm to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].